Perioperative evaluation and management of patients with cirrhosis: risk assessment, surgical outcomes, and future directions

KL Newman, KM Johnson, PB Cornia, P Wu… - Clinical …, 2020 - Elsevier
Background and Aims Patients with cirrhosis are at increased risk of perioperative morbidity
and mortality. We provide a narrative review of the available data regarding perioperative …

Recommendations of the Polish Group of Experts for HCV for the treatment of hepatitis C in 2023

K Tomasiewicz, R Flisiak, J Jaroszewicz… - Clinical and …, 2023 - termedia.pl
The recommendations define the principles of diagnosis and treatment of hepatitis C virus
(HCV) infection according to the latest knowledge. The main goal of the treatment of HCV …

Early mortality after liver transplantation: defining the course and the cause

F Baganate, EW Beal, D Tumin, D Azoulay, K Mumtaz… - Surgery, 2018 - Elsevier
Background The objective of the current study was to define the incidence, as well as time
course of mortality within the first year after liver transplantation. Methods Data on adult, first …

[HTML][HTML] The impact of direct-acting antiviral agents on liver and kidney transplant costs and outcomes

DA Axelrod, MA Schnitzler, T Alhamad… - American journal of …, 2018 - Elsevier
Direct-acting antiviral medications (DAAs) have revolutionized care for hepatitis C positive
(HCV+) liver (LT) and kidney (KT) transplant recipients. Scientific Registry of Transplant …

Recommendations of the Polish Group of Experts for HCV for the treatment of hepatitis C in 2020

W Halota, R Flisiak, J Juszczyk, P Małkowski… - Clinical and …, 2020 - termedia.pl
The recommendations set out the principles of diagnosis and treatment of hepatitis C virus
(HCV) infections according to the most recent knowledge. The main goal of therapy for HCV …

Pretransplantation splenomegaly frequently persists after liver transplantation and can manifest as hypersplenism and graft fibrosis‐a retrospective study

NH Nam, K Taura, S Yao, T Kaido… - Transplant …, 2020 - Wiley Online Library
The risk factors and clinical impact of post‐transplantation splenomegaly (SM) are poorly
understood. We investigated the predictors and impacts of post‐transplantation SM in 415 …

[HTML][HTML] Clinical considerations in the management of non-alcoholic steatohepatitis cirrhosis pre-and post-transplant: a multi-system challenge

JA Steggerda, K Mahendraraj, T Todo… - World Journal of …, 2020 - ncbi.nlm.nih.gov
Non-alcoholic steatohepatitis (NASH) is the most common chronic liver disease worldwide,
and the fastest growing indication for liver transplantation in the United States. NASH is now …

Effectiveness and safety of sofosbuvir‐based therapy against chronic hepatitis C infection after successful kidney transplantation

J Musialik, A Kolonko, K Kwiecień… - Transplant Infectious …, 2019 - Wiley Online Library
Abstract Background Direct‐acting antivirals (DAAs), including sofosbuvir (SOF), are
recommended for treatment of chronic hepatitis C virus (HCV) infection. However, few …

How to manage a patient with chronic liver disease undergoing colorectal surgery?

B Dupont, A Alves - Seminars in Colon and Rectal Surgery, 2023 - Elsevier
The indications for colorectal surgery in cirrhotic patients have recently been broadened,
mostly due to a better understanding and multidisciplinary management of cirrhosis …

Заболевания печени и гемостаз (обзор) Часть I. Нехолестатические заболевания печени и гемостаз

ВИ Решетняк, ИВ Маев, ТМ Решетняк… - Общая …, 2019 - cyberleninka.ru
При заболеваниях печени, особенно в терминальной стадии печеночной
недостаточности, развиваются разнообразные гемостатические дефекты, которые …